Aztreonam-amoxicillin/clavulanate combination therapy against <i>bla</i> NDM-producing Enterobacterales infections
Our findings suggest aztreonam/amoxicillin-clavulanate combination therapy guided by gradient strip-crossing as a potential broad-spectrum-sparing strategy for selected patients with NDM-producing Enterobacterales infections.
Authors
- Daniel Grupel (ORCID: https://orcid.org/0000-0002-8315-1204)
- Efrat Orenbuch‐Harroch
- Jacob Strahilevitz (ORCID: https://orcid.org/0000-0002-9192-7164)
- Dan Reshef
- Yonatan Oster (ORCID: https://orcid.org/0000-0002-1050-1648)
- Jacob Moran‐Gilad (ORCID: https://orcid.org/0000-0001-9134-050X)
- Violeta Temper
- Gabriella Snoyman
- Munther Aqeel Nashashibi
Institutions
- Hebrew University of Jerusalem (IL)
- Hadassah Medical Center (IL)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1093/jac/dkaf379
- Citations
- 1
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.59